skip to main content
Show Results with:

A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial

Gastric Cancer, 2018, Vol.21(5), pp.811-818 [Peer Reviewed Journal]

Full text available

Searching Remote Databases, Please Wait